GILD Andrew D Dickinson sells $13.8M worth of shares
Mar 27, 2025, 10:31 AM
-5.58%
What does GILD do
Gilead Sciences, headquartered in Foster City, California, employs 18,000 people and focuses on developing medicines for HIV, hepatitis, COVID-19, and cancer. Its portfolio includes numerous marketed products and several promising candidates.
Andrew D Dickinson sold 142,180 shares of GILD on 31 January at $97.22 per share, worth a total of $13.8M. They now own 129,873 GILD shares, or a 52% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.